Viewing Study NCT00716157


Ignite Creation Date: 2025-12-24 @ 6:43 PM
Ignite Modification Date: 2026-02-02 @ 10:10 PM
Study NCT ID: NCT00716157
Status: COMPLETED
Last Update Posted: 2014-12-05
First Post: 2008-07-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation
Sponsor: Thomas Jefferson University
Organization:

Study Overview

Official Title: A Prospective Study to Evaluate the Incidence and Patterns of Nausea and Vomiting in Patients Receiving Combined Chemotherapy and Radiation
Status: COMPLETED
Status Verified Date: 2014-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Questionnaire study to observe the incidence and pattern or nausea and vomiting in patients receiving combined chemotherapy and radiation. 83% of patients experience radiation therapy-induced vomiting; significant nausea and vomiting could develop with concurrent chemotherapy despite standard anti-nauseous medication prophylaxis.
Detailed Description: Questionnaires will be answered daily on a weekly basis during period of radiation and chemotherapy.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
2004-16 OTHER CCRRC View
1002004024 OTHER_GRANT Merck View